PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.
Zhou Q, Zhou Q, Liu Q, He Z, Yan Y, Lin J, Chen Z, He C, Mao K, Wang J, Zhou Z, Xiao Z, Zhang J.
Zhou Q, et al. Among authors: zhang j.
Theranostics. 2020 Aug 18;10(22):10345-10359. doi: 10.7150/thno.42069. eCollection 2020.
Theranostics. 2020.
PMID: 32929353
Free PMC article.